Fig. 2From: Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching studySurvival analysis at 12 months. Notes : A Kaplan-Meier survival analysis was performed for the warfarin vs. rivaroxaban groups at 12 months, and group comparisons were performed using the log-rank test (p = 0.61)Back to article page